Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olfr819 Inhibitors

Direct inhibitors for Olfr819 are not well-characterized, leading to the consideration of indirect modulation through chemicals that influence olfactory GPCR signaling pathways. Forskolin, IBMX, and U73122 are examples that modulate second messengers like cAMP and intracellular signaling molecules, which are crucial in GPCR-mediated responses. Pertussis toxin and BAPTA-AM provide insights into the role of G-proteins and calcium in GPCR signaling, which are essential components in the functioning of olfactory receptors.

Furthermore, kinase inhibitors like Genistein, PD98059, LY294002, Wortmannin, SB203580, GF109203X, and Go 6983 target various signaling cascades that can indirectly impact GPCR activity. These inhibitors offer a broader perspective on the signaling networks associated with olfactory receptors, providing an indirect approach to understanding and potentially modulating the activity of receptors like Olfr819. However, the specificity of these chemicals towards Olfr819 is not established, and their effects on this particular receptor require careful experimental validation. This approach allows for exploring the complex signaling mechanisms in olfactory perception and potentially identifying novel modulators of olfactory receptors.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Activates adenylate cyclase, potentially modulating GPCR signaling including that of Olfr819.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$159.00
$315.00
$598.00
34
(1)

Non-selective phosphodiesterase inhibitor, affecting cAMP levels and possibly GPCR signaling.

Pertussis Toxin (islet-activating protein)

70323-44-3sc-200837
50 µg
$442.00
3
(1)

Modifies G-proteins, potentially affecting Olfr819 signaling cascade.

BAPTA/AM

126150-97-8sc-202488
sc-202488A
25 mg
100 mg
$138.00
$449.00
61
(2)

Calcium chelator, can influence signaling pathways of GPCRs.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$26.00
$92.00
$120.00
$310.00
$500.00
$908.00
$1821.00
46
(1)

Tyrosine kinase inhibitor, may indirectly affect GPCR signaling.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

MEK inhibitor, potentially affecting MAPK/ERK pathways downstream of GPCR activation.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

PI3K inhibitor, potentially affecting signaling pathways downstream of GPCRs.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

p38 MAPK inhibitor, potentially influencing signaling pathways related to GPCR activity.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

PI3K inhibitor, may affect GPCR-related signaling pathways.

Bisindolylmaleimide I (GF 109203X)

133052-90-1sc-24003A
sc-24003
1 mg
5 mg
$103.00
$237.00
36
(1)

Protein kinase C inhibitor, might influence GPCR signaling.